JACC: CardioOncology serves to advance the cardiovascular care of cancer patients through the publication of rigorously executed, innovative science and dissemination of evidence-based knowledge. The journal seeks to transform the field of cardio-oncology and actively engage and educate the cardiovascular and oncology communities in pre-clinical, translational, and clinical research, as well as in best practices in cardio-oncology. Broad areas of interest include original research studies in disease mechanisms, in vitro and in vivo model systems, novel and conventional therapeutics (Phase I-IV), epidemiology, precision medicine, and primary and secondary prevention. Disease states of interest include, but are not limited to amyloidosis, cardiovascular risk factors, heart failure, and vascular disease.
- Original Research Papers
- State-of-the-Art Review Articles
- Primers in Research and Clinical Medicine
- Research Letters
- Clinical Case Challenges
- Letters to the Editor
- Editor’s Pages from the Editor-in-Chief or other invited thought leaders